Standout Papers
- Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. (2002)
Immediate Impact
1 by Nobel laureates 9 from Science/Nature 71 standout
Citing Papers
Fluorescent Probes for Disease Diagnosis
2024 Standout
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
2023 Standout
Works of F. Cardenal being referenced
3BA A phase II trial of erlotinib (E) and bevacizumab (B) in patients with advanced non-small-cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations with and without T790M mutation. The Spanish Lung Cancer Group (SLCG) and the European Thoracic Oncology Platform (ETOP) BELIEF trial
2015
Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.
2002 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| F. Cardenal | 620 | 579 | 17 | 409 | 26 | 930 | |
| Elisa Chiadini | 456 | 489 | 17 | 227 | 28 | 785 | |
| Shinnosuke Ikemura | 473 | 471 | 27 | 489 | 45 | 932 | |
| Satoshi Yoda | 647 | 481 | 23 | 635 | 26 | 1.1k | |
| L Pyle | 351 | 293 | 23 | 435 | 18 | 796 | |
| S. Srinivas | 512 | 278 | 27 | 403 | 37 | 794 | |
| Tiffany G. Huynh | 560 | 748 | 25 | 374 | 20 | 1.2k | |
| Annick Haller | 604 | 511 | 37 | 464 | 22 | 1.1k | |
| Carmen Nuzzo | 309 | 474 | 23 | 396 | 30 | 990 | |
| Susan Schumer | 333 | 413 | 27 | 501 | 17 | 1.1k | |
| Tingsheng Peng | 458 | 319 | 12 | 597 | 28 | 1.1k |
All Works
Loading papers...